home about team portfolio news investor login contact
Chris Albinson
Shahan Soghikian

Life Sciences
Rod Ferguson
Damion Wicker

Ann Parsons
Audrey Vallen

Advisory Boards
Advisory Boards
Panorama Panorama Capital evaluates hundreds of investment opportunities each year. We draw from a broad network of entrepreneurs, industry executives and venture capital firms with whom we have worked before. This network is comprised of:

Technology Advisory Boards
Our technology advisory board consists of leading executives, technologists and influencers across the core sectors where we invest: applications, infrastructure, and core technology. Members of our advisory boards represent leading companies such as Google, Twitter, Apple, Facebook, Yahoo!, Microsoft, AT&T, Nokia, Cisco Systems, Samsung, Texas Instruments, Nvidia, Applied Materials, Agilent and Hewlett Packard.

CIO Council
Our CIO Council consists of leaders in enterprise information technology. They are an instrumental part of our efforts at indentifying enterprise trends, providing product feedback and understanding technology adoption. Representative companies include Abercrombie & Fitch, Equifax, HJ Heinz, Latham & Watkins, Silicon Valley Bank, Red Hat, Zynga and Snap-On, Inc.Life Sciences Advisory Boards. Our life sciences advisory board consists of leaders from academic medicine, industry and government with scientific, drug development, regulatory, and reimbursement expertise. Members of our advisory board work or have previously worked with the Federal Drug Administration, at leading biopharmaceutical companies, such as Genentech, Gilead, and Myogen and at premiere academic medical centers, such as Stanford and the University of California at San Francisco and San Diego.

We interact with these advisors, both individually and in groups, on a regular basis to leverage their extensive industry experience in their respective fields of specialization. These individuals consistently help the team refine key investment themes, source unique investment opportunities, assess technical, product and market risks in new deals and provide post-investment input and support to accelerate company growth.